Feedback / Questions
FYB206 (pembrolizumab biosimilar) - Formycon, MS Pharma
https://www.manilatimes.net/2025/12/09/tmt-newswire/globenewswire/formycon-and-zydus-partner-for-exclusive-licensing-and-supply-agreement-of-fyb206-a-biosimilar-to-keytruda-pembrolizumab-in-the-us-and-canada/2239796
Dec 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next